Mepolizumab provides a small reduction in the exacerbations of moderate to severe eosinophilic COPD

Mepolizumab provides a small reduction in the exacerbations of moderate to severe eosinophilic COPD is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Mepolizumab provides a small reduction in the exacerbations of moderate to severe eosinophilic COPD ID - 1314425 ED - Barry,Henry, ED - Ebell,Mark H, ED - Shaughnessy,Allen F, ED - Slawson,David C, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314425/all/Mepolizumab_provides_a_small_reduction_in_the_exacerbations_of_moderate_to_severe_eosinophilic_COPD PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -